Release Date: 22/01/10 16:34 Summary: Notice of General Meeting, IER and Proxy Form Price Sensitive: No Download Document 1.8MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%